Lockheed Martin Expands Defense Portfolio with $3.45 Billion Ultra Maritime Acquisition
Lockheed Martin's $3.45 billion acquisition of Ultra Maritime signals a strategic push into undersea warfare amid rising NATO defense budgets.
Canada Diagnostic Centres Expands Operations with Shift Imaging Acquisition
Canada Diagnostic Centres enhances its diagnostic imaging network with the acquisition of Shift Imag…
Ondas Holdings Expands Portfolio with $875.8M Acquisition of DZYNE
Ondas Holdings is set to acquire DZYNE for $875.8M, marking a significant move in the defense sector…
Solstice's $14.5B Acquisition of Element Solutions: A Game-Changer in Critical Minerals
Solstice Advanced Materials confirms a $14.5B acquisition of Element Solutions, reshaping the critic…
Vera Therapeutics Sees Stock Surge Ahead of Critical FDA Decision on Atacicept
Vera Therapeutics' stock jumped ahead of a pivotal FDA decision on atacicept, snapping a three-sessi…
Prestige Consumer Healthcare's Successful LaCorium Acquisition and Debt Financing
Prestige Consumer Healthcare strengthens its portfolio with LaCorium acquisition and a $400M senior …
Incyte's Strategic Acquisition of Vega Therapeutics Enhances Hematology Portfolio
Incyte's acquisition of Vega Therapeutics marks a significant strategic move to bolster its hematolo…
AXT Inc. Secures Multi-Year Supply Agreement: Implications for the Semiconductor Market
AXT Inc. inks a three-year deal with Coherent, signaling growth potential in the semiconductor marke…
AbbVie’s Skyrizi Gets FDA Green Light for Pediatrics: A Game Changer for Growth Investors
AbbVie (ABBV) stock rose 3.44% following FDA approval for Skyrizi's pediatric use, signaling potenti…
CRISPR Therapeutics and Vertex Pharmaceuticals Gain FDA Approval: What It Means for Investors
CRISPR Therapeutics and Vertex Pharmaceuticals see significant market movement following FDA approva…